Hematuria Found Years After BT

May 2013
Renal & Urology News;May2013, Vol. 12 Issue 5, p28
The article presents the study conducted by researchers at Mount Sinai School of Medicine in New York regarding gross hematuria may occur in men after undergoing prostate brachytherapy.


Related Articles

  • Evaluating interstitial radiation therapy for prostate carcinoma. Ellis, Rod J.; Resnick, Martin I. // Contemporary Urology;Apr2001, Vol. 13 Issue 4, p12 

    Discusses the use of brachytherapy for the treatment of prostate carcinoma. Advantages and disadvantages to any of available isotopes used in prostate brachytherapy; Techniques for transperineal implantation; Post-operative evaluation; Results; Conclusion.

  • New prostate treatment may increase awareness. Berkman, Sue // Westchester County Business Journal;7/26/99, Vol. 38 Issue 30, p21 

    Reports on developments in the treatment of prostate cancer. Adoption of the prostate-specific antigen test for early detection of prostate cancer; Seed implant or radioisotope brachytherapy that involves implanting of radioactive palladium.

  • Long-term brachytherapy data build. Guttman, Cheryl // Urology Times;Oct95, Vol. 23 Issue 10, p15 

    Focuses on the use of brachytherapy as treatment for prostate cancer. Development of techniques to enhance the use of brachytherapy; Treatment outcomes.

  • Brachytherapy may not be indicated in higher-risk PCa patients. Guttman, Cheryl // Urology Times;Nov98, Vol. 26 Issue 11, p3 

    Details findings of a retrospective cohort study from the University of Pennsylvania which cautions urologists about overapplying interstitial seed implantation or brachytherapy as a definitive treatment for localized prostate cancer. Use of multivariable analytic techniques to compare...

  • Will seeds soon replace scalpels for treating prostate cancer? Overmyer, Mac // Urology Times;Jan97, Vol. 25 Issue 1, p40 

    Reports on the use of brachytherapy for treating organ-confined prostate cancer. Results in patients who underwent brachytherapy with Iodine 125 seeds; Low postoperative morbidity; Side effects.

  • Brachytherapy's appeal leads to improved technology. Scheck, Anne // Urology Times;May99, Vol. 27 Issue 5, p14 

    Reports on the technological improvements in the field of prostate cancer treatment due to the increasing popularity of permanent prostate brachytherapy (PPB). Potential improvement of dose calculation modes; Improvement of image handling and display; Introduction of innovative methods of...

  • Several options viable if seed implants fail. Scheck, Anne // Urology Times;May99, Vol. 27 Issue 5, p14 

    Reports on doctor Bradley R. Prestidge's claims about the viability of several options for the treatment of prostate cancer after the failure of brachytherapy. Determination of the cause of the failure; Necessity of knowing the extent and grade of the tumor by histopathologic techniques;...

  • Brachytherapy gaining respect for low-risk PCa. Scheck, Anne // Urology Times;May99, Vol. 27 Issue 5, p18 

    Reports on the increasing popularity of brachytherapy among physicians in the United States as treatment modality for low-risk prostate cancer (PCa). Patients' increasing demand for the technology; Empirical findings supporting the efficacy of brachytherapy; Emergence of external beam...

  • St. Luke's doctors perform new treatment for prostate cancer.  // Hudson Valley Business Journal;11/23/98-11/30/98, Vol. 9 Issue 15, p27 

    Reports that St. Luke's Hospital in Newburgh, New York, performed its brachytherapy, a radiation seed implantation procedure to treat prostate cancer patients. Demographics for prostate cancer; Other treatment options; Description of brachytherapy; Comments from Laurence Kelly, executive vice...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics